Quantcast
Home / Top Stories / Federal law would create competition among drug firms (access required)

Federal law would create competition among drug firms (access required)

Federal legislation that would expedite the arrival of generic versions of biotechnology drugs onto the market has stirred up controversy in the U.S. Senate and among the nation’s biotech firms. Senators Charles Schumer, a Democrat from New York, and Susan Collins, a Republican from Maine, have introduced legislation that would limit the exclusivity period for ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

 

Scroll To Top